Case Studies
1812 Ashland Accelerator Feasibility Study
VaLogic conducted a feasibility study for Johns Hopkins University, assessing supply and demand for early-stage lab space and proposing a program that addressed lab areas, size, and functions, along with finishes and infrastructure requirements.
1812 Ashland Accelerator
Following a feasibility study to assess demand for early-stage lab space in the Baltimore area, the next step was to create an accelerator/innovation hub for lab-based companies, with VaLogic engaged to assist in the construction.
Arcellx
Arcellx is developing CAR-T technologies to tackle multiple myeloma with a more efficacious and calcitrant treatment than is currently available. Early success has allowed Arcellx and Kite Pharma to enter into a co-development partnership.
Barinthus Biotherapeutics (formerly Vaccitech)
Barinthus Biotherapeutics develops immunotherapeutic products and vaccines for the treatment and prevention of infectious disease and cancer. The company needed a larger facility for a new office headquarters and R&D facility. The solution: VaLogic's Owner’s Representation service.
Capital Digestive Care
CDC needed a core laboratory with new technology evaluation capabilities. VaLogic was engaged to conduct the expansion’s feasibility study, then provided project management and facility management services throughout construction and operations startup.
CvilleBioHub Feasibility Study
Our engagement in the CvilleBioHub project involved conducting a comprehensive survey to assess the space requirements for a multi-tenant life science lab facility. Based on this survey, we developed a program, capital budget, operating budget, and operational framework to support the development of the proposed facility.
Innovation Ecosystem Market Assessment for the Delaware Prosperity Partnership
VaLogic conducted a thorough market analysis of key industries in Delaware, including chemistry, advanced materials, biotech, medical device, and healthcare. Our assessment empowered the Delaware Prosperity Partnership to attract investment and drive sustainable economic growth in Wilmington and the surrounding region.
MaxCyte®
Scattered operations and a lack of facility cohesion prevented MaxCyte from fully realizing the opportunity represented by the more than 50,000 ongoing cell and gene therapy clinical trials. Operations needed to be brought together and facilities repurposed and relocated for consolidation. VaLogic offered the specialized, cross-disciplinary expertise necessary for success.
On-Demand Pharmaceuticals
On-Demand Pharmaceuticals (ODP) is developing a mobile, vending machine-like dispensary for front-line military, first responders, and other remote locations. VaLogic helped the state and economic development teams recruit ODP to Maryland from Virginia.
Sirnaomics
With 16 clinical trials currently underway, Sirnaomics needed a new headquarters and lab to accommodate the company’s unique operational needs for a higher-than-average chemical fume density, a small animal vivarium, and the use of disposable technology. The solution: VaLogic’s Owner’s Representation service to shepherd the project from capital budget to completion.
United Therapeutics
United Therapeutics created the Dinutuximab-Dedicated Oncology Medical and Analytical Laboratory (DDOMAL) to expand commercial manufacturing capacity for its pediatric high-risk neuroblastoma therapy. This facility won the International Society for Pharmaceutical Engineering’s Facility of the Year Award (FOYA) in 2020.
Vita Therapeutics
Vita Therapeutics is a cell engineering company developing cellular treatment for muscular dystrophy and solid tumors. The challenge: To expand the company’s Maryland presence. The solution: A new Current Good Manufacturing Practices (cGMP) mixed-use facility developed by VaLogic.
Have a question or need a quote? Give us a call!
Maryland Offices
Frederick Office (HQ)
- Mon-Fri (8AM-5PM) EST
- 21 Byte Ct, Frederick, MD
- contactus@valogicbio.com
- (240) 529-1673
Burtonsville Office
- Mon-Fri (8AM-5PM) EST
- 3901 National Drive, Burtonsville, MD
- contactus@valogicbio.com
- (240) 560-5588
Massachusetts Office
- Mon-Fri (7:30AM-4:30PM) EST
- 33 Wales Ave, Suite A, Avon, MA, 02322
- contactus@valogicbio.com
- (508) 427-5558
Texas Office
- Mon-Fri (7:30AM-4:30PM) CDT
- 7255 Helix Park Avenue, Portal Innovations Suite 300, Houston, TX
- contactus@valogicbio.com
- (713) 477-9247